Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Use of PEG 3350 in Constipation
NCT00153153Phase 4Completed
- Sponsor
- Braintree Laboratories
- Start
- Aug 2003
- Primary completion
- Dec 2004
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol 3350 in chronic constipation, sponsored by Braintree Laboratories. Started Aug 2003; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00153153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153153.